Next steps in oncology payment reform

Slides:



Advertisements
Similar presentations
Blending Supply-Side Approaches with Consumerism Paul B. Ginsburg, Ph.D. Presentation to Second National Consumer-Driven Healthcare Summit, September 26,
Advertisements

Making Payment Reforms Work for Patients and Families Lee Partridge Senior Health Policy Advisor National Partnership for Women and Families January 28,
The Advanced Medical Home ACP Attributes of Advanced Medical Home Evidence-based care/clinical decision support Chronic care model approach for all patients.
THE COMMONWEALTH FUND Figure 1. More Than Two-Thirds of Opinion Leaders Say Current Payment System Is Not Effective at Encouraging High Quality of Care.
Pilgrimage Healthcare Patients Deserve More Options…
Idaho Medical Home Pilot A Multi-payer Initiative Denise Chuckovich, Deputy Director Idaho Department of Health and Welfare
Cancer Care Delivery Reform: The Payer’s Perspective Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Michael.
Aetna and PCMH Improving Employee Health through Patient- Centered Medical Homes Morristown, New Jersey October 12, 2010 Aetna’s experience with Patient-Centered.
Designing Successful Strategies and Alliances. Clinical Quality – Integrity – Service Excellence – Teamwork – Accountability – Continuous Improvement.
Tracey Moorhead President and CEO May 15, 2015 No Disclosures ©AAHCM.
CONFIDENTIAL AND PROPRIETARY - 1 Quality Satisfaction Efficiency Bringing You More Than Ever Before LVBCH June 23, 2015.
Evolving the Oncology Medical Home Dr. Michael Kolodziej, National Medical Director, Oncology Solutions, Aetna Kathy Lokay, President and CEO, Via Oncology.
The Community Oncology Conference April 23, 2014 Oncology Payment Reform Tammy Chambers Director of Contracting The Center for Cancer and Blood Disorders.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
Next Steps in Oncology Payment Reform for Established Provider & Payer Teams Presented By: Robert Baird CEO, Dayton Physicians Network Community Oncology.
11 Creating Value from EMR Investment Kevin Maben, MD, FAAP Associate Medical Information Officer Presbyterian Healthcare Services.
Practice Transformation: Using Technology to Improve Models of Care and Transitions in Care Mat Kendall, EVP Aledade DISCLAIMER: The views and opinions.
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Tom Grote, CEBS President, North Capitol Market Aetna Virginia.
Maine State Innovation Model (SIM) August 2, 2013.
Better, Smarter, Healthier: Delivery System Reform U.S. Department of Health and Human Services 1.
Effectiveness and Cost of a Transitional Care Program for Heart Failure Arch Intern Med. 2011;171(14): September 11, 2012 Brett Stauffer MD MHS.
CHCWM/Priority Health Oncology Medical Home March 6, 2013.
HFMA – Physician Perspective on Key Issues April 5, 2013.
Accountable Care Organizations: Payer and provider collaborations to increase population health Continuing Education: Iowa.
Nancy Mamo, Managing Director, Population Health Analytics, BCBSRI
Telemedicine: The Future of People Caring for People
Changing Nature of Managed Care Organization-Provider Relationships
Wireless Access SSID: cwag2017
EVP, Chief Medical Officer CEO Advocate Physician Partners
The Value of Access: Partnering with Commercial Payors Alyssa Rose, JD, MSW, Director of Network Strategy, Beacon Health Options.
Session Overview - Introduction - Significance of Post‐Acute Care - Impacts of Post‐Acute Care Performance - Mandatory Elements of Reform - Understanding.
Epocrates Online physician user survey
Why pricing transparency?
The potential of Interventional radiology
Carol Callaghan Michigan Department of Community Health and
What’s Next for Maryland Hospitals HFMA Maryland Chapter
State Payment Reform Bringing physicians together for a healthier Ohio
Bundled Payments: An Initiative of Payment Reform
Understanding Costs and Demonstrating Your Impact
Bringing You More Than Ever Before
An Economic Perspective
“The Integrator” Optimal Care for All our Members and Patients
2017 Patient Navigation Best Practices
Brass Tacks: The Money Problem
Medication Therapy management
Paying for Serious Illness Care Under a Global Budget: Opportunities and Challenges Anna Gosline, Senior Director of Health Policy and Strategic Initiatives,
MHA 628 Competitive Success/snaptutorial.com
MHA 628 Education for Service/snaptutorial.com
Value Based Contracting in Action
Pacific Business Group on Health (PBGH) System Transformation
The potential of Interventional radiology
Texas Primary Care and Health Home Summit
The National Academies of Sciences, Engineering, and Medicine
Ivy Tech Community College Limited Medical Insurance Plans
Oncology Care Model 2.0 The Universal Payment Model in Oncology
Organizational Culture in the Oncology Medical Home
Prior authorization and patient cost-sharing are least likely to be seen as effective in reducing unnecessary care. “How effective do you think each of.
Kathy Clodfelter, MSN, MBA, RN, NE-BC
Component 1: Introduction to Health Care and Public Health in the U.S.
Payment Reform to Transform Advanced Illness Care
The Future of Biologics in Part D
Provider Peer Grouping: Project Overview
Medicare: Risks and Opportunities for 2019
Designing new payment models for Medical Care: Version 2009 (PCMH) Presentation to The Medical Home Summit Bob Doherty Senior Vice President, Governmental.
Value-Based Healthcare: The Evolving Model
Successful Financing Strategies to Capitalize RHIOs
Transforming Perspectives
Cost and Performance Management Under Alternative Payment Models
Medicaid Collaboration
Presentation transcript:

Next steps in oncology payment reform Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Next steps in oncology payment reform Michael Kolodziej, M.D., FACP National Medical Director, Oncology Solutions Aetna

Aetna Values & Oncology Solutions Mission Statement Aetna Oncology Solutions – Mission Statement: We give our members access to high-value, personalized cancer care models. We collaborate with oncology teams that deliver best-in-class care by using evidence-based medical guidelines, clinical decision support tools and services that improve the patient’s experience, increase effectiveness of care and lower costs. Our value-based approach, powered by data analytics and transparency of policy and payment, allows us to move from a fee-for-service platform to a value-driven system that rewards Oncology practices for quality care throughout the patient’s care journey.  

Payers are horrified by the cost of cancer care and perceived low value

Responses to the huge and growing expense of cancer care? Pay less Manage more (prior auth) Narrow networks Shift responsibility to member (co-pay) Pay for performance (process measures) Shift risk (capitation) Impact has been small Aggravation has been large

Who are the players and why The practice perspective: size, sophistication, personality The payer perspective: size, sophistication, personality CMS has changed the playing field

You cannot improve a process that is not measured BREAST   ABC ONCOLOGY - BREAST 2012 2013 COMMERCIAL MEDICARE Grand Total - FOCUS BCL MEMBERS 542 6 548 93 FOCUS MBR CHEMO COSTS AT PRAC (TIME PERIOD) $12,336,674 $24,740 $12,811,033 $898,159 AVG PMPY $22,761 $4,123 $23,378 $9,658 ACTIVE CHEMO MBR MONTHS @ PRAC 2,707 18 2,658 407 ACTIVE CHEMO PMPM @ PRAC $4,557 $1,374 $4,820 $2,207 AVG ACTIVE CHEMO MONTHS SEEN** 5.0 3.0 4.9 4.4 IP FOCUS MBR AVG LOS AVG LOS 4.99 6.50 5.69 7.04 ER VISITS PER FOCUS MBR PY VISITS 1.60 1.00 1.49 FOCUS MBR YRLY MCC COSTS (SEE BELOW) $26,510,932 $94,050 $28,019,064 $2,325,577 AVG FOCUS MCC COST PMPY $48,913 $15,675 $51,130 $25,006 FOCUS MCC CATEGORY BREAKDOWN AMB FACILITY - UPMPY UPMPY $6,489 $690 $7,118 $1,555 EMERGENCY - UMPY $2,560 $0 $3,494 $624 IP FACILITY - UMPY $22,842 $169 $26,037 $20,476 LAB - UMPY $700 $972 $808 $389 MEDICAL RX - UPMPY $35,125 $9,735 $36,296 $18,349 RADIOLOGY - UPMPY $10,959 $7,900 $11,053 $4,926 SPEC PHYSICIAN $2,237 $1,198 $2,699 $2,042

Where are we now? Pathways (get over it) Pay for value

What is the role of the consumer?

What are the threats? Cost of innovation Consolidation of providers

Copyright © 2015 American Medical Association. All rights reserved. From: Five Years of Cancer Drug Approvals:  Innovation, Efficacy, and Costs JAMA Oncol. Published online April 02, 2015. doi:10.1001/jamaoncol.2015.0373 Copyright © 2015 American Medical Association. All rights reserved.

Where are we going? Episode based reimbursement

Cost of Care is Greatest During Periods of Active Treatment

There is tremendous consistency across disease states

Episode fee plasticity based on clinical performance Basic Episode Fee Reduced Episode Fee Enhanced Episode Fee Determinants of modifier: ER visits, Hospitalizations, Generic prescribing, Hospice Enrollment

The challenge is managing high-cost outliers

The Oncology Patient Centered Medical Home: Aetna Pilot Experience Proprietary & Confidential